a phase i/ii trial of glofitamab monotherapy in r/r mcl
Published 2 weeks ago • 29 plays • Length 1:45Download video MP4
Download video MP3
Similar videos
-
10:41
trial updates in follicular lymphoma from ash 2019
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
3:32
the use of surrogate endpoints in cll clinical trials
-
2:35
next questions for mantle cell lymphoma
-
9:25
mgus diagnosis: a step-by-step approach
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
5:00
introducing the direct-safe trial
-
1:55
the real-world efficacy of brentuximab vedotin consolidation post-autosct in r/r hl
-
2:59
clinical trials and novel agents under investigation in t-cell lymphoma
-
5:25
pivotal findings from a phase i/ii trial of mosunetuzumab monotherapy for r/r follicular lymphoma
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
3:33
the growing role of machine learning in hematological oncology
-
1:46
current treatment approaches in et and an insight into the surpass-et trial
-
5:07
daratumumab in the management of al amyloidosis
-
1:12
is it feasible to use imaging modalities as an endpoint in myeloma clinical trials?
-
1:00:27
new directions for clinical trials in oncology
-
1:04:44
cell and gene therapy clinical trials: how to successfully operationalize a trial
-
1:47
shared treatment decision-making
-
6:14
horizon scan of car-t for lymphoma
-
2:18
the emn22 trial: daratumumab monotherapy in newly diagnosed stage 3b al amyloidosis
-
2:17
extended follow-up of the master trial